Tech2 weeks ago
Ocaliva approval in Europe withdrawn following data re-assessment – Pharmaceutical Technology
The European Commission (EC) followed a CHMP recommendation that the drug’s benefits do not outweigh its risks. Image credit: Shutterstock / Mukul_1122. Advanz Pharma said it...